GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chosa Oncology AB (XSAT:CHOSA) » Definitions » Price-to-Free-Cash-Flow

Chosa Oncology AB (XSAT:CHOSA) Price-to-Free-Cash-Flow : 53.16 (As of Jun. 06, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Chosa Oncology AB Price-to-Free-Cash-Flow?

As of today (2024-06-06), Chosa Oncology AB's share price is kr1.01. Chosa Oncology AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.02. Hence, Chosa Oncology AB's Price-to-Free-Cash-Flow Ratio for today is 53.16.

The historical rank and industry rank for Chosa Oncology AB's Price-to-Free-Cash-Flow or its related term are showing as below:

XSAT:CHOSA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 4.7   Max: 57.63
Current: 52.89

During the past 9 years, Chosa Oncology AB's highest Price-to-Free-Cash-Flow Ratio was 57.63. The lowest was 0.00. And the median was 4.70.

XSAT:CHOSA's Price-to-Free-Cash-Flow is ranked worse than
67.59% of 216 companies
in the Biotechnology industry
Industry Median: 30.425 vs XSAT:CHOSA: 52.89

Chosa Oncology AB's Free Cash Flow per Share for the three months ended in Dec. 2023 was kr0.03. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was kr0.02.

During the past 9 years, Chosa Oncology AB's highest 3-Year average Free Cash Flow per Share Growth Rate was 79.10% per year. The lowest was -112.30% per year. And the median was -18.30% per year.


Chosa Oncology AB Price-to-Free-Cash-Flow Historical Data

The historical data trend for Chosa Oncology AB's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chosa Oncology AB Price-to-Free-Cash-Flow Chart

Chosa Oncology AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only - - - - 29.68

Chosa Oncology AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.70 0.81 0.44 29.68

Competitive Comparison of Chosa Oncology AB's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Chosa Oncology AB's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chosa Oncology AB's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chosa Oncology AB's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Chosa Oncology AB's Price-to-Free-Cash-Flow falls into.



Chosa Oncology AB Price-to-Free-Cash-Flow Calculation

Chosa Oncology AB's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.01/0.019
=53.16

Chosa Oncology AB's Share Price of today is kr1.01.
Chosa Oncology AB's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Chosa Oncology AB  (XSAT:CHOSA) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Chosa Oncology AB Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Chosa Oncology AB's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Chosa Oncology AB (XSAT:CHOSA) Business Description

Traded in Other Exchanges
N/A
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.

Chosa Oncology AB (XSAT:CHOSA) Headlines

No Headlines